Definition:Disclosure schedule
📝 Disclosure schedule is a set of annexes or exhibits attached to a definitive agreement in an insurance transaction, in which the seller itemizes exceptions, qualifications, and supplementary information relating to the warranties and representations contained in the agreement. While serving a function broadly analogous to the disclosure letter used in UK-style transactions, disclosure schedules are the predominant disclosure mechanism in US-governed insurance M&A deals and are increasingly encountered in cross-border transactions where the purchase agreement follows American drafting conventions.
🗂️ Each disclosure schedule is typically numbered to correspond to a specific section of the definitive agreement. For example, a schedule might list all pending claims or litigation against the target insurer, detail all reinsurance contracts with change of control provisions, enumerate material contracts including binding authority agreements and treaty placements, or identify known regulatory inquiries. In insurance-specific deals, schedules covering reserve methodologies, actuarial opinions, capital adequacy calculations, and policyholder complaints are common additions that would not typically appear in a non-insurance acquisition. The schedules interact with the warranties through carefully negotiated "disclosure schedule qualifiers" — language in each warranty that carves out matters set forth in the corresponding schedule from being treated as breaches. Negotiation over what must appear in the schedules, and what level of detail is sufficient, is often intense, particularly for items such as reserve development trends and pending regulatory matters that could signal future financial exposure.
🎯 Disclosure schedules matter because they form the evidentiary foundation upon which post-closing indemnity claims and warranty disputes are adjudicated. If a material fact — say, an emerging mass tort exposure or an adverse regulatory finding — was properly disclosed in the schedules, the buyer's ability to seek compensation under the warranties is typically extinguished for that item. Conversely, if the seller failed to disclose a known issue, the schedules become the buyer's roadmap for demonstrating breach. In insurance transactions, where latent liabilities can surface long after closing, the completeness and accuracy of the disclosure schedules have consequences that persist for years. As warranty and indemnity insurance becomes standard in the US insurance M&A market, W&I carriers now conduct granular reviews of the disclosure schedules as part of their underwriting process, further raising the bar for disclosure quality.
Related concepts: